Literature DB >> 18842676

Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?

Claudia Sommerer, Thomas Giese, Stefan Meuer, Martin Zeier.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18842676     DOI: 10.1093/ndt/gfn556

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  8 in total

Review 1.  Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis.

Authors:  Kannan Sridharan; Gowri Sivaramakrishnan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

2.  TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy and reduces renal dysfunction in a cyclosporine A-induced nephrotoxicity model.

Authors:  Raj Kumar Yadav; Geum-Hwa Lee; Hwa-Young Lee; Bo Li; Han-Eul Jung; Harun-Or Rashid; Min Kyung Choi; Binod Kumar Yadav; Woo-Ho Kim; Kyung-Woon Kim; Byung-Hyun Park; Won Kim; Yong-Chul Lee; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 3.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients.

Authors:  Sarah Leyking; Karin Budich; Kai van Bentum; Stephan Thijssen; Hashim Abdul-Khaliq; Danilo Fliser; Martina Sester; Urban Sester
Journal:  J Transl Med       Date:  2015-02-06       Impact factor: 5.531

5.  Differential T Cell Signaling Pathway Activation by Tacrolimus and Belatacept after Kidney Transplantation: Post Hoc Analysis of a Randomised-Controlled Trial.

Authors:  Nynke M Kannegieter; Dennis A Hesselink; Marjolein Dieterich; Gretchen N de Graav; Rens Kraaijeveld; Carla C Baan
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

6.  A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis.

Authors:  Stefanie Marx; Claudia Adam; Janine Mihm; Michael Weyrich; Urban Sester; Martina Sester
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

7.  Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study.

Authors:  Florentine Garaix; Marc Stern; François-Xavier Lamy; Laurence Dubel; Nassim Kamar
Journal:  Ann Transplant       Date:  2018-08-10       Impact factor: 1.530

8.  Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial.

Authors:  Allison B Webber; Vasishta Tatapudi; Thin T Maw; Carmen Peralta; Joey C Y Leung; Flavio Vincenti
Journal:  Transplant Direct       Date:  2018-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.